ADTRAN
27.2.2024 14:01:49 CET | Business Wire | Press release
Adtran today announced that Telstra has successfully trialed its FSP 150 edge compute device, opening the door to enhanced network services for business customers across Australia. By incorporating Red Hat’s OpenShift software directly onto Adtran’s hosting platform, Telstra succeeded in facilitating the efficient management and operation of small applications right at the device edge. The solution will enable multiple applications to run on a single device, reducing the need for additional hardware investments. This approach will empower businesses to derive new value from their existing hardware, leading to a reduction in inventory sprawl and power usage, and making operations more environmentally friendly. The collaboration shows the potential for Telstra customers to benefit from operational efficiency gains while also delivering enhanced control over network security and data usage.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240227823763/en/
Telstra is using Adtran’s FSP 150 to show how businesses can unlock more value from their networks with edge compute devices. (Photo: Business Wire)
“This initiative pushes the boundaries of how device edge capabilities will enhance the way businesses operate, helping them do more with less and generate more value from existing hardware,” said Channa Seneviratne, technology development and innovation executive at Telstra. “Alongside simplification, this trial demonstrates how we can enable a more distributed and intelligent network with better resiliency, performance and workload distribution. It’s another step forward in our ambition to unlock more value for customers and continue to drive technology leadership.”
Telstra’s successful trial of Red Hat’s Linux-based OS and OpenShift Container Platform on Adtran FSP 150 devices makes it possible to leverage new capabilities from hardware already sitting in customers’ networks. This approach boosts value, reduces additional investment needs and enhances operational efficiency. Hosting applications at the network edge also brings about stronger security, better data management and improved network reliability, all while streamlining the deployment and management of applications. What’s more, the strategy promotes innovation and equips businesses to adapt to future technological changes and market demands. The edge hosting device utilized in the trial was the FSP 150-XG304u, which is powered by a robust Intel Xeon D processor. Offering substantial bandwidth and processing power, it’s ideal for hosting multiple revenue-generating applications at the edge.
“Together with Telstra and Red Hat, we’re helping transform traditional edge hardware into versatile devices capable of running multiple applications. By enabling operators like Telstra to host VNFs directly at the network edge, we’re optimizing response times and reducing the need for extensive backhaul bandwidth, leading to significant energy and opex savings. Bringing cloud capabilities to the edge also eliminates the need for additional network elements and extra space at the customer premises, ensuring a more streamlined and cost-efficient infrastructure,” commented Anthony Camilleri, APAC CTO at Adtran. “Our FSP 150 Series merges top-tier Carrier Ethernet functionality with the flexibility of open hosting for edge cloud applications. This empowers operators to provide reliable business-class data services alongside innovative end-user services, all within a single carrier-class device.”
About Adtran
ADTRAN Holdings, Inc. (NASDAQ: ADTN and FSE: QH9) is the parent company of Adtran, Inc., a leading global provider of open, disaggregated networking and communications solutions that enable voice, data, video and internet communications across any network infrastructure. From the cloud edge to the subscriber edge, Adtran empowers communications service providers around the world to manage and scale services that connect people, places and things. Adtran solutions are used by service providers, private enterprises, government organizations and millions of individual users worldwide. ADTRAN Holdings, Inc. is also the largest shareholder of Adtran Networks SE, formerly ADVA Optical Networking SE. Find more at Adtran, LinkedIn and X.
Published by
ADTRAN Holdings, Inc.
www.adtran.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240227823763/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Empire State Building Observation Deck to Debut ‘Olympus Awaits,’ An Immersive ‘Percy Jackson and the Olympians’ Takeover in the Heart of NYC, On Display from Nov. 16 – Dec. 4*12.11.2026 23:07:00 CET | Press release
The multi-level takeover includes a Throne Room, interactive photo opportunities, special lighting, and more The Empire State Building (ESB) is the gateway to Mount Olympus in Percy Jackson’s world, and now fans can experience the magic like never before. On Nov. 16, the Empire State Building Observation Deck (ESBOD) will unveil “Olympus Awaits,” a multi-level “Percy Jackson and the Olympians” takeover, in partnership with Disney+. The immersive takeover – included with every Observation Deck ticket – will feature an epic Throne Room, interactive photo opportunities, surprise giveaways, ESB x “Percy Jackson” merch, and more, available through Dec. 4, 2026.* This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112442266/en/ Empire State Building Observation Deck to Debut ‘Olympus Awaits,’ An Immersive ‘Percy Jackson and the Olympians’ Takeover in the Heart of NYC, On Display from Nov. 16 – Dec. 4* “This immersive NYC experience
Clene Nanomedicine Partners with Veristat to Reduce Biostatistical Output Time by 80% for ALS New Drug Application12.11.2026 18:09:00 CET | Press release
Veristat’s InStat™ delivers submission-ready tables, listings, and figures (TLFs) in one week using validated statistical engines, shortening the critical path from database lock to submission VeristatTM, a global clinical research organization (CRO) and consultancy specializing in complex studies, announced that it has partnered with Clene Nanomedicine to cut the time to deliver biostatistical outputs for a pivotal ALS drug application submission by 80%. Veristat reduced the time from study data to validated tables, listings and figures (TLFs) from up to six weeks to just one week. Clene, a late-stage biotech company, leveraged Veristat’s recently launched InStat™ platform, the industry’s first zero-code, fully automated solution to accelerate clinical trial processes. Biostatistical TLFs sit on the critical path for submissions, yet most sponsors rely on antiquated processes that involve slow, manual workflows to produce them, making post-database lock one of the biggest bottlenecks
WHOOP Launches WHOOP Humans, the Most Verifiably Human Social Network12.11.2026 18:00:00 CET | Press release
New feature lets members follow friends and family, share performance and health insights, and celebrate life's moments together WHOOP, the human performance brand, today launched WHOOP Humans, a new feature that lets members follow friends and family, share fitness, health, and performance data they choose, and support each other's progress. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112176779/en/ WHOOP Launches WHOOP Humans, the Most Verifiably Human Social Network For more than a decade, WHOOP has helped members better understand their own health and performance. Now, WHOOP Humans extends that experience beyond the individual, making it easier to celebrate achievements, encourage progress, and look out for the people who matter most. "In a world that's becoming increasingly artificial, we're building something deeply human,” said Will Ahmed, Founder and CEO of WHOOP. “This is the most verifiably human network ever
Integrated Hubs for Green Chemistry Research Aim to Transform How Chemicals and Materials Are Designed12.11.2026 17:00:00 CET | Press release
International network will investigate fundamental principles for creating safer, higher-performing chemicals and materials The Gordon and Betty Moore Foundation today announced four Integrated Research Hubs to explore new frontiers in chemical design, from materials that respond to their surroundings to molecules designed for safety from the start. Bringing together global researchers across institutions and disciplines, the hubs will investigate fundamental principles that could enable new capabilities in chemicals and materials while improving performance and protecting human health and the environment. The research priorities emerged through extensive engagement with the scientific community to identify the questions that could transform what chemistry can achieve. Each hub will connect researchers across institutions around one of four green chemistry focus areas: Safer molecular design: Led by The George Washington University, this hub will combine artificial intelligence and qua
Roquette Highlights Scalable Excipient and Capsule Solutions for Regional and Global Pharmaceutical Markets at CPHI India 202612.11.2026 16:00:00 CET | Press release
Helping pharmaceutical manufacturers accelerate the journey from formulation to market through deep technical expertise, meaningful innovation, close collaboration and global capabilities Roquette, a global leader in plant-based ingredients and a leading provider of pharmaceutical excipients, will showcase its comprehensive portfolio of excipient and capsule solutions at CPHI India 2026, Hall 1, Booth 1I12 from November 23 to 25, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112803410/en/ Meet Roquette at CPHI India 2026, Hall 1, Booth 1I12 At the event, Roquette will demonstrate how it helps pharmaceutical manufacturers accelerate the journey from formulation to market with confidence. By combining technical expertise, trusted quality, meaningful innovation and close collaboration, Roquette helps customers address formulation, scale-up and manufacturing challenges across a broad range of pharmaceutical application
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
